Resources from the same session
First-Line Treatment for Advanced NSCLC without Oncogenic Addiction
Presenter: C. Mascaux, FR
Session: Session 4 - Advanced NSCLC
Resources:
Slides
Second-Line Treatment for Advanced NSCLC
Presenter: N. Mejri, TN
Session: Session 4 - Advanced NSCLC
Resources:
Slides
Best Strategy for Advanced NSCLC with KRAS Mutation
Presenter: Laura Mezquita, ES
Session: Session 4 - Advanced NSCLC
Resources:
Slides
Participant Clinical Case Discussion: Kras G12C Mutated Lung Adenocarcinoma
Presenter: H. El Yacoubi, MA
Session: Session 4 - Advanced NSCLC
Resources:
Slides
Participant Clinical Case Discussion: Advanced NSCLC with EGFR Mutation
Presenter: M. Benaradj, DZ
Session: Session 4 - Advanced NSCLC
Resources:
Slides
Participant Clinical Case Discussion: EGFR Exon 20 Insertion Mutation in a 24 Year Old Patient
Presenter: M. Hammami, TN
Session: Session 4 - Advanced NSCLC
Resources:
Slides
Participant Clinical Case Discussion: Management of Metastatic NSCLC ALK Positive: The Added Value of the Liquid Biopsy
Presenter: H. Inrhaoun, MA
Session: Session 4 - Advanced NSCLC
Resources:
Slides